GALE : Analysis & Opinions

  1. Why 78% Is Galena Biopharma's Magic Number

    June 29, 2015
    Have you ever had a feeling of deja vu? You know, that uncanny feeling that you're experiencing something you've been through ...
  2. What's Behind Galena's 58% Rise in 2 Weeks?

    June 10, 2015
    Within the biotechnology sector there pretty much hasn't been a hotter company over the last two weeks than Galena Biopharma ...
  3. 5 Things Galena Biopharma Wants You to Know

    May 28, 2015
    In early May, Galena Biopharma (NASDAQ: GALE), a predominantly clinical-stage biopharmaceutical company focused on developing ...
  4. Galena Biopharma Earnings: NeuVax or Bust

    May 8, 2015
    Predominantly clinical-stage biopharmaceutical companies often get a pass come earnings time, but when remaining cash on ...
  5. 4 Ways Galena Biopharma Could Disappoint Investors

    March 31, 2015
    When it comes to investing in small-cap biotech stocks, the chips are firmly stacked in favor of the pessimists. Although ...
  6. Should You Leave Galena To The Day Traders?

    March 9, 2015
    There are few sectors as exciting as the biotech sector, and shareholders of Galena Biopharma have certainly been privy to ...
Trading Center